![](https://sp-ao.shortpixel.ai/client/to_auto,q_glossy,ret_img,w_326,h_245/https://healthylivinglinks.com/wp-content/uploads/2021/10/Picture2-326x245.png)
Low-dose Gout Drug, Colchicine, Has Been Approved to Reduce Cardiovascular Events in Patients with Coronary Disease
Pendopharm, a division of Pharmascience Inc., has announced an existing anti-inflammatory gout drug as a new repurposed treatment. In August 2021, Health Canada issued a […]